marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
EyePoint Pharmaceuticals Total Liabilities 2011-2024 | EYPT
Annual Total Liabilities EyePoint Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88.9 M | 84 M | 79 M | 73.2 M | 64.6 M | 60 M | 5.34 M | 10.7 M | 9 M | 7.75 M | 8.55 M | 6.96 M | 9.68 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 88.9 M | 5.34 M | 39.1 M |
Quarterly Total Liabilities EyePoint Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.2 M | 95.9 M | 88.9 M | 101 M | 118 M | 76.2 M | 84 M | 84.1 M | - | 77.7 M | 79 M | 75.5 M | 72 M | 71.4 M | 73.2 M | 73.2 M | 73.2 M | 73.2 M | 64.6 M | 64.6 M | 64.6 M | 64.6 M | 40.5 M | 40.5 M | 40.5 M | 40.5 M | 4.29 M | 4.33 M | 5.34 M | 5.34 M | 4.98 M | 10.5 M | 10.7 M | 10.7 M | 9.53 M | 8.64 M | 9 M | 9 M | 7.9 M | 7.94 M | 7.75 M | 7.75 M | 8.22 M | 8.5 M | 8.55 M | 8.55 M | 7.23 M | 7.18 M | 6.96 M | 6.96 M | 7.16 M | 7.91 M | 9.68 M | 9.68 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 118 M | 4.29 M | 38.5 M |